Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantationZAMAGNI, Elena; PATRIARCA, Francesca; PANTANI, Lucia et al.Blood. 2011, Vol 118, Num 23, pp 5989-5995, issn 0006-4971, 7 p.Article

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 studyCAVO, Michele; TACCHETTI, Paola; OFFIDANI, Massimo et al.Lancet (British edition). 2010, Vol 376, Num 9758, pp 2075-2085, issn 0140-6736, 11 p.Article

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of ThrombosisZAMAGNI, Elena; BRIOLI, Annamaria; TACCHETTI, Paola et al.Seminars in thrombosis and hemostasis. 2011, Vol 37, Num 3, pp 209-219, issn 0094-6176, 11 p.Article